Medically reviewed by Soma Mandal, MD Petechiae are tiny red, purple, or brown spots on your skin, inside of your mouth, or ...

Marine-derived lipids, including omega-3 fatty acids, are emerging as potential game-changers in cancer therapy. Research ...

Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...

A phase 3 trial confirms “the potent anti-leukemic effect” of consolidation with allogeneic transplant in older patients with acute myeloid leukemia, according to researchers.

Related to the last question, Dietrich and colleagues 32 administered the commonly used chemotherapy agents BCNU, cisplatin and cytosine arabinoside (cytarabine) systemically to mice. These ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad ...

It has two candidates in phase 3 – lurbinectedin for small-cell lung cancer and JZP351 (liposomal daunorubicin and cytarabine) for acute myeloid leukaemia. The deal is also a first partnership ...

Background: Compared with high-income countries, the survival rate of childhood cancer is lower in low- and middle-income countries. Access to essential anticancer medicines is an indispensable ...

Non-Hodgkin lymphoma treatment (PDQ) - Patient version. American Cancer Society. Key statistics for childhood leukemia. Fala L. Daurismo (Glasdegib) approved, in combination with low-dose cytarabine, ...

The medicines and health conditions are: venetoclax (brand name Venclexta) in combination with azacitidine or cytarabine for a type of blood cancer called acute myeloid leukaemia azacitidine to be ...

Background A growing evidence base supports the use of autologous haematopoietic stem cell transplantation (aHSCT) for treatment of relapsing-remitting multiple sclerosis (RRMS), but it has not yet ...